Since evidence has showed that a number of different inflammatory cells and mediators play roles in the progression of COPD, interleukin-6 (IL-6) has become a subject of considerable research in recent years (Garcia-Rio et al., 2010). The gene discussed is IL6; the disease is chronic obstructive pulmonary disease.